Discovery and optimization of phthalazinone derivatives as a new class of potent dengue virus inhibitors

被引:13
|
作者
Lu, Dong [2 ,3 ]
Liu, Jianan [2 ,3 ]
Zhang, Yunzhe [1 ]
Liu, Feifei [2 ,3 ]
Zeng, Limin [2 ]
Peng, Runze [2 ,3 ]
Yang, Li [2 ]
Ying, Huazhou [1 ]
Tang, Wei [2 ]
Chen, Wuhong [2 ]
Zuo, Jianping [2 ]
Tong, Xiankun [2 ]
Liu, Tao [1 ]
Hu, Youhong [1 ,2 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Zhejiang, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China
[3] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China
基金
中国国家自然科学基金;
关键词
Phthalazinone; Dengue virus; Inhibitor; Optimization; SAR; INFECTION; PERSPECTIVE; PROSPECTS; PROGRESS;
D O I
10.1016/j.ejmech.2018.01.008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Using a dengue replicon cell line-based screening, we identified 3-(dimethylamino)propyl(3-((4-(4-fluorophenyl)-1-oxophthalazin-2(1H)-yl)methypphenyl)carbamate (10a) as a potent DENV-2 inhibitor, with an IC50 value of 0.64 mu M. A series of novel phthalazinone derivatives based on hit 10a were synthesized and evaluated for their in vitro anti-DENV activity and cytotoxicity. The subsequent SAR study and optimization led to the discovery of the most promising compound 141, which displayed potent anti-DENV-2 activity, with low IC50 value against DENV-2 RNA replication of 0.13 mu M and high selectivity (SI = 89.2) with acceptable pharmacokinetics profiles. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:328 / 337
页数:10
相关论文
共 50 条
  • [1] Discovery and Optimization of 2,4-Diaminoquinazoline Derivatives as a New Class of Potent Dengue Virus Inhibitors
    Chao, Bo
    Tong, Xian-Kun
    Tang, Wei
    Li, De-Wen
    He, Pei-Lan
    Garcia, Jean-Michel
    Zeng, Li-Min
    Gao, An-Hui
    Yang, Li
    Li, Jia
    Nan, Fa-Jun
    Jacobs, Michael
    Altmeyer, Ralf
    Zuo, Jian-Ping
    Hu, You-Hong
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (07) : 3135 - 3143
  • [2] Molecular docking and QSAR theoretical model for prediction of phthalazinone derivatives as new class of potent dengue virus inhibitors
    Adawara, Samuel Ndaghiya
    Shallangwa, Gideon Adamu
    Mamza, Paul Andrew
    Ibrahim, Abdulkadir
    BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, 2020, 9 (01)
  • [3] Molecular docking and QSAR theoretical model for prediction of phthalazinone derivatives as new class of potent dengue virus inhibitors
    Samuel Ndaghiya Adawara
    Gideon Adamu Shallangwa
    Paul Andrew Mamza
    Abdulkadir Ibrahim
    Beni-Suef University Journal of Basic and Applied Sciences, 9
  • [4] Lead Optimization of Spiropyrazolopyridones: A New and Potent Class of Dengue Virus Inhibitors
    Zou, Bin
    Chan, Wai Ling
    Ding, Mei
    Leong, Seh Yong
    Nilar, Shahul
    Seah, Peck Gee
    Liu, Wei
    Karuna, Ratna
    Blasco, Francesca
    Yip, Andy
    Chao, Alex
    Susila, Agatha
    Dong, Hongping
    Wang, Qing Yin
    Xu, Hao Ying
    Chan, Katherine
    Wan, Kah Fei
    Gu, Feng
    Diagana, Thierry T.
    Wagner, Trixie
    Dix, Ina
    Shi, Pei-Yong
    Smith, Paul W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (03): : 344 - 348
  • [5] Discovery of Indole Derivatives as Novel and Potent Dengue Virus Inhibitors
    Bardiot, Dorothee
    Koukni, Mohamed
    Smets, Wim
    Carlens, Gunter
    McNaughton, Michael
    Kaptein, Suzanne
    Dallmeier, Kai
    Chaltin, Patrick
    Neyts, Johan
    Marchand, Arnaud
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (18) : 8390 - 8401
  • [6] Discovery of Phthalazinone Derivatives as Novel Hepatitis B Virus Capsid Inhibitors
    Chen, Wuhong
    Liu, Feifei
    Zhao, Qiliang
    Ma, Xinna
    Lu, Dong
    Li, Heng
    Zeng, Yanping
    Tong, Xiankun
    Zeng, Limin
    Liu, Jia
    Yang, Li
    Zuo, Jianping
    Hu, Youhong
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (15) : 8134 - 8145
  • [7] Discovery, synthesis and optimization of a new class of potent KDR inhibitors: naphthoylamides
    Harmange, Jean-Christophe
    Bajpai, Manoj
    Bauer, David
    Bellon, Steven
    Borg, George
    Bready, James
    Choquette, Deborah
    Coxon, Angela
    Demelfi, Thomas
    Dipietro, Lucian
    Doerr, Nicholas
    Estrada, Juan
    Flynn, Shaun
    Germain, Julie
    La, Daniel
    Morrison, Michael
    Patel, Vinod
    Van der Plas, Simon
    Polverino, Anthony
    Potashman, Michele
    Powers, David
    Starnes, Charlie
    Weiss, Matthew
    Whittington, Douglas
    Zanon, Roger
    CANCER RESEARCH, 2006, 66 (08)
  • [8] In Silico Studies of Oxadiazole Derivatives as Potent Dengue Virus Inhibitors
    Samuel Ndaghiya Adawara
    Gideon Adamu Shallangwa
    Paul Andrew Mamza
    Abdulkadir Ibrahim
    Chemistry Africa, 2021, 4 : 861 - 868
  • [9] In Silico Studies of Oxadiazole Derivatives as Potent Dengue Virus Inhibitors
    Adawara, Samuel Ndaghiya
    Shallangwa, Gideon Adamu
    Mamza, Paul Andrew
    Ibrahim, Abdulkadir
    CHEMISTRY AFRICA-A JOURNAL OF THE TUNISIAN CHEMICAL SOCIETY, 2021, 4 (04): : 861 - 868
  • [10] Discovery of Dengue Virus Inhibitors
    Abdullah, Adib Afandi
    Lee, Yean Kee
    Chin, Sek Peng
    Lim, See Khai
    Lee, Vannajan Sanghiran
    Othman, Rozana
    Othman, Shatrah
    Rahman, Noorsaadah Abdul
    Yusof, Rohana
    Heh, Choon Han
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (30) : 4945 - 5036